Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea
1 other identifier
observational
500
1 country
1
Brief Summary
To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2023
CompletedFirst Submitted
Initial submission to the registry
January 3, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2033
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 7, 2033
December 11, 2025
April 1, 2025
10 years
January 3, 2024
November 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Multiple-omics features
ELISA ,proteomics and metabolomics were performed on blood, saliva, urine
Within 24 hours of admission,and samples of patients receiving treatment were also collected six months and one year after treatment
Study Arms (3)
Severe OSA
Non-severe OSA
Healthy controls
Eligibility Criteria
Patients with obstructive sleep apnea.
You may qualify if:
- Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University.
- Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.
You may not qualify if:
- Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation;
- Pregnant or lactating women;
- Patients with severe respiratory failure requiring mechanical ventilation;
- Patients with severe heart, lung, liver, kidney, and central nervous system damage;
- Refuse to participate in follow-up visits and/or take biological samples.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Chaoyang hospital affiliated to Capital Medical University
Beijing, Beijing Municipality, 100020, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 3, 2024
First Posted
December 11, 2025
Study Start
August 7, 2023
Primary Completion (Estimated)
August 7, 2033
Study Completion (Estimated)
August 7, 2033
Last Updated
December 11, 2025
Record last verified: 2025-04